Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harun Fajkovic

Showing results (21-30 of 142) with videos related to

Pageof 15
Sort By:
International Journal of Surgical Pathology|July 7, 2023
Metastatic Translocated Renal Cell Carcinoma in a Kidney Transplant Patient - a Case Report and Review of the LiteratureJohannes Kläger, Manuela Schmidinger, André Oszwald, et al.
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|January 15, 2019
Role of lasers in urologyStephan M Korn, Nicolai A Hübner, Christian Seitz, et al.
Current Opinion in Urology|May 9, 2021
Adverse events of systemic immune-based combination therapies in the first-line treatment of patients with metastatic renal cell carcinoma: systematic review and network meta-analysisFahad Quhal, Keiichiro Mori, Mesut Remzi, et al.
Current Opinion in Urology|November 1, 2021
Immunotherapy-based combinations in the first-line treatment of metastatic renal cell carcinoma with sarcomatoid features: a systematic review and network meta-analysisFahad Quhal, Keiichiro Mori, Harun Fajkovic, et al.
Translational Andrology and Urology|October 28, 2016
Female with bladder cancer: what and why is there a difference?Phillip Marks, Armin Soave, Shahrokh F Shariat, et al.
Current Opinion in Urology|March 20, 2021
Dual immune check point blockade or immune check point-tyrosine kinase inhibitor combination: as a first-line treatment in metastatic renal cell carcinoma?Manuela Schmidinger, Irene Resch, Harun Fajkovic, et al.
World Journal of Urology|May 27, 2023
A 10-year renaissance of en bloc resection of bladder tumors (ERBT): Are we approaching the peak or is it back to the trough?Dmitry Enikeev, Andrey Morozov, Anastasia Shpikina, et al.
European Urology|January 13, 2006
Extracorporeal shock wave lithotripsy in the treatment of proximal ureteral stones: Does the presence and degree of hydronephrosis affect success?Christian Seitz, Harun Fajkovic, Matthias Waldert, et al.
Current Opinion in Urology|July 18, 2022
Molecular biomarkers to help select neoadjuvant systemic therapy for urothelial carcinoma of the bladderEkaterina Laukhtina, Benjamin Pradere, Ursula Lemberger, et al.
World Journal of Urology|September 28, 2012
Results and outcomes after endoscopic treatment of upper urinary tract carcinoma: the Austrian experienceHarun Fajkovic, Tobias Klatte, Udo Nagele, et al.
Pageof 15

Showing results (21-30 of 142) with videos related to

Sort By:
Pageof 15
International Journal of Surgical Pathology|July 7, 2023
Metastatic Translocated Renal Cell Carcinoma in a Kidney Transplant Patient - a Case Report and Review of the LiteratureJohannes Kläger, Manuela Schmidinger, André Oszwald, et al.
Photochemical & Photobiological Sciences : Official Journal of the European Photochemistry Association and the European Society for Photobiology|January 15, 2019
Role of lasers in urologyStephan M Korn, Nicolai A Hübner, Christian Seitz, et al.
Current Opinion in Urology|May 9, 2021
Adverse events of systemic immune-based combination therapies in the first-line treatment of patients with metastatic renal cell carcinoma: systematic review and network meta-analysisFahad Quhal, Keiichiro Mori, Mesut Remzi, et al.
Current Opinion in Urology|November 1, 2021
Immunotherapy-based combinations in the first-line treatment of metastatic renal cell carcinoma with sarcomatoid features: a systematic review and network meta-analysisFahad Quhal, Keiichiro Mori, Harun Fajkovic, et al.
Translational Andrology and Urology|October 28, 2016
Female with bladder cancer: what and why is there a difference?Phillip Marks, Armin Soave, Shahrokh F Shariat, et al.
Current Opinion in Urology|March 20, 2021
Dual immune check point blockade or immune check point-tyrosine kinase inhibitor combination: as a first-line treatment in metastatic renal cell carcinoma?Manuela Schmidinger, Irene Resch, Harun Fajkovic, et al.
World Journal of Urology|May 27, 2023
A 10-year renaissance of en bloc resection of bladder tumors (ERBT): Are we approaching the peak or is it back to the trough?Dmitry Enikeev, Andrey Morozov, Anastasia Shpikina, et al.
European Urology|January 13, 2006
Extracorporeal shock wave lithotripsy in the treatment of proximal ureteral stones: Does the presence and degree of hydronephrosis affect success?Christian Seitz, Harun Fajkovic, Matthias Waldert, et al.
Current Opinion in Urology|July 18, 2022
Molecular biomarkers to help select neoadjuvant systemic therapy for urothelial carcinoma of the bladderEkaterina Laukhtina, Benjamin Pradere, Ursula Lemberger, et al.
World Journal of Urology|September 28, 2012
Results and outcomes after endoscopic treatment of upper urinary tract carcinoma: the Austrian experienceHarun Fajkovic, Tobias Klatte, Udo Nagele, et al.
Pageof 15